Literature DB >> 2829268

Aversive property of opioid receptor blockade in drug-naive mice.

R F Mucha1, M J Walker.   

Abstract

The motivational effect of naloxone administration in the non-dependent laboratory mouse was examined with taste and place conditioning procedures. Thus, male CD1 mice without any history of drug exposure avoided a cue paired with three SC injections of as little as 0.1 mg/kg naloxone HCl. The aversive effect of naloxone was also seen in DBA/2 and C57BL/6 mice. In addition, it only occurred with the minus isomer and not the plus isomer, and it was potentiated by implantation, 3 days prior to training, of a morphine-containing (37.5 mg) but not a placebo pellet. Naloxone injection, therefore, acts as an aversive stimulus in naive mice and this is probably produced by decreases in activity of endogenous opioid peptide systems. Together with other data, the present results support the conclusion that the aversive effect of opioid receptor blockade in the opiate non-dependent organism may be general to a wide range of species including primates. The importance of training and testing variables for observing the naloxone aversive effect is discussed. Advantages of studying preference conditioning with mice are also given.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829268     DOI: 10.1007/BF00207239

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin.

Authors:  R F Mucha; M J Millan; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Negative reinforcing properties of morphine-antagonists in naive rhesus monkeys.

Authors:  F Hoffmeister; W Wuttke
Journal:  Psychopharmacologia       Date:  1973

3.  An accurate, inexpensive, calibrated drinking tube.

Authors:  R J Robbins
Journal:  Lab Anim Sci       Date:  1977-12

4.  Naloxone administration following brief exposure to novelty reduces activity and rearing in mice upon 24-h retest: a conditioned aversion?

Authors:  R J Rodgers; C Richards; J I Precious
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors:  P Grevert; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

6.  Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

Authors:  H W Kosterlitz; A J Watt
Journal:  Br J Pharmacol Chemother       Date:  1968-06

7.  Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice.

Authors:  R J Rodgers; J I Randall
Journal:  Pharmacol Biochem Behav       Date:  1985-11       Impact factor: 3.533

8.  Drug reinforcement studied by the use of place conditioning in rat.

Authors:  R F Mucha; D van der Kooy; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

9.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  The painlike effect of gallamine and naloxone differs from sickness induced by lithium chloride.

Authors:  B T Lett
Journal:  Behav Neurosci       Date:  1985-02       Impact factor: 1.912

View more
  12 in total

1.  Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

Authors:  C Lee; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  The role of opioid processes in reward and decision-making.

Authors:  Vincent Laurent; Ashleigh K Morse; Bernard W Balleine
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

3.  Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.

Authors:  Jen-Hsin Kao; Man-Jun Gao; Pao-Pao Yang; Ping-Yee Law; Horace H Loh; Pao-Luh Tao
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

4.  Mouse strain differences in opiate reward learning are explained by differences in anxiety, not reward or learning.

Authors:  C L Dockstader; D van der Kooy
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

5.  Naloxone effects on extinction of ethanol- and cocaine-induced conditioned place preference in mice.

Authors:  Laura Font; Christa A Houck; Christopher L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  2017-06-26       Impact factor: 4.530

6.  Genetic differences in the rewarding and activating effects of morphine and ethanol.

Authors:  C L Cunningham; D R Niehus; D H Malott; L K Prather
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Genetic differences in naloxone enhancement of ethanol-induced conditioned taste aversion.

Authors:  J Broadbent; H V Linder; C L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

8.  Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Authors:  Wojciech Solecki; Anna Turek; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-09-29       Impact factor: 4.530

9.  Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning.

Authors:  Catherine M Davis; Glenn W Stevenson; Fernando Cañadas; Thomas Ullrich; Kenner C Rice; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

10.  Expression pattern of neural synaptic plasticity marker-Arc in different brain regions induced by conditioned drug withdrawal from acute morphine-dependent rats.

Authors:  Mu Li; Yuan-yuan Hou; Bin Lu; Jie Chen; Zhi-qiang Chi; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.